Alamar Biosciences, Inc. (ALMR) Live Share Price, Invest From India

Alamar Biosciences, Inc. Stock Performance

as on September 4, 2026 at 2:09 am IST

Day's Low
Day's High
$29.60
Day's Price Range
$31.05
$30.31
2.34%
Downside
2.44%
Upside
52 Week's Low
52 Week's High
52-Week Price Range
$30.31
100.00%
Downside
-100.00%
Upside

Alamar Biosciences, Inc. share price movements today

Previous Close: $30.49
Open: $31.00
Volume: 35.2K
Market Cap: $2.1B
Day's Low - High: $29.60 - $31.05

Alamar Biosciences, Inc. Historical Returns

1 Month Return: + 15.77 %
3 Month Return: + 41.15 %
1 Year Return: 0 %
3 Year Return: 0 %
5 Year Return: 0 %

Alamar Biosciences, Inc. Stock Fundamentals & Key Indicators

Check Alamar Biosciences, Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$2.1B

EPS (TTM)

-0.53

Dividend Yield

0.00%

PE Ratio (TTM)

-62.3

Industry PE ratio

20.266153846153845

PEG Ratio

-0.6230188679245283

Return On Equity TTM

428.55%

Alamar Biosciences, Inc. Stock Valuation

Track how Alamar Biosciences, Inc. P/E has moved over time to understand its valuation trends.

Alamar Biosciences, Inc. in the last 1 year

Overview
Trends

Lowest (-48.89x)

December 31, 2025

Today (-48.89x)

December 31, 2025

Industry (20.27x)

December 31, 2025

Highest (-48.89x)

December 31, 2025

LowHigh

Today’s Price to Earnings Ratio: -48.89x

Alamar Biosciences, Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Alamar Biosciences, Inc. with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %	Dividend Yield %
Alamar Biosciences, Inc.	StrongBuy	$2.1B	NA	-62.3	58.01%	NA
Edwards Lifesciences	BUY	$52.3B	-24.77%	53.2	77.98%	NA
Medtronic	BUY	$116.0B	-31.69%	24.15	65.02%	3.15%
Stryker	BUY	$124.2B	14.3%	32.62	65.17%	1.0999999999999999%
Abbott Laboratories	BUY	$201.9B	-15.22%	35.71	11.65%	213.54999999999998%

See all

Analyst Recommendation on Alamar Biosciences, Inc. Stock

Based on 4 analysts

BUY

75.00%

Buy

25.00%

Hold

0.00%

Sell

Based on 4 analysts, 75% of analysts recommend a 'BUY' rating for Alamar Biosciences, Inc.. Average target price of $33

Indian Investors' Interest in Alamar Biosciences, Inc. Stock

Search interest for Alamar Biosciences, Inc. Stock has increased by 271% in the last 30 days, reflecting an upward trend in search activity.

Time period: August 4, 2026 to September 3, 2026

Change:271% versus previous 30 day period

Alamar Biosciences, Inc. Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2026	Jun 2026
Total Revenue	26	29
Gross Profit	14	17
Operating Income	-12	-13
EBITDA	-19	-13
Interest Expense	0	0
Depreciation	1	-
Income Before Tax	-20	-13
Income Tax Expense	0	0
Net Income	-21	-13
Net Profit Margin	55.53%	60.21%

Alamar Biosciences, Inc. Annual Profit & Loss

All numbers in Millions USD

	Dec 2025
Total Revenue	74
Gross Profit	41
Operating Income	-31
EBITDA	-24
Interest Expense	0
Depreciation	3
Income Before Tax	-29
Income Tax Expense	0
Net Income	-29
Net Profit Margin	56.20%

Alamar Biosciences, Inc. Quarterly Cash Flow

All numbers in Millions USD

	Mar 2026	Jun 2026
Net Income	-21	-13
Operating Cash Flow	-20	-11
Investing Cash Flow	0	-120
Financing Cash Flow	55	201
Change in Cash	64	74

Alamar Biosciences, Inc. Annual Cash Flow

All numbers in Millions USD

	Dec 2025
Net Income	-29
Operating Cash Flow	-53
Investing Cash Flow	46
Financing Cash Flow	10
Change in Cash	3

Mutual Funds that own Alamar Biosciences, Inc. Stock

Check out the Mutual Funds with significant holdings in Alamar Biosciences, Inc..

Funds	Holdings	Shares Held
AB CAP FUND, INC.	0.599494%	416006
Principal Funds, Inc	0.307167%	213152
Fidelity Advisor Series VII	0.2421%	168000
FINANCIAL INVESTORS TRUST	0.223867%	155348
LORD ABBETT SECURITIES TRUST	0.041288%	28651

See all

Global Institutional Holdings in Alamar Biosciences, Inc.

Funds	Holdings
Cathie Wood	1.98%
ARK	1.54%
James E. Flynn	0.86%
Vanguard	0.79%
Andrew J.M. Spokes	0.67%

See all

Insights on Alamar Biosciences, Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Price Rise
In the last 3 months, ALMR stock has moved up by 45.6%

About Alamar Biosciences, Inc.

Alamar Biosciences, Inc., a proteomics company, develops a proteomic liquid biopsy platform and sells instruments, consumables, and services to early detection of diseases. The company develops NULISA technology, a proteomics platform that detects and quantifies protein biomarkers. It offers ARGO high throughput (HT) System, a fully automated precision proteomics platform, performs ultra-high sensitivity and multiplexed analysis to support biomarker analysis across the continuum of discovery, translational research and ultimately, and diagnostics. The company's offering is utilized in research areas including immunology, neurology, and oncology. It serves global research and academic institutions, biopharmaceutical companies, contract research organizations, and service labs. The company operates in the United States, rest of Europe, Middle East and Africa, Germany, Asia Pacific, and internationally. It has a strategic partnership with Alzheimer's Disease Data Initiative, and Gates Ventures to advance translational research in alzheimer's disease. The company was incorporated in 2018 and is based in Fremont, California.

Organisation	Alamar Biosciences, Inc.
Headquarters	47071 Bayside Parkway, Fremont, CA, United States, 94538
Industry	Medical Devices
CEO	Dr. Yuling Luo Ph.D.
E-voting on shares	Click here to vote

Key Management of Alamar Biosciences, Inc.

Name	Title
Dr. Shiping Chen Ph.D.	Co-Founder, COO & Director
Mr. Justin J. McAnear	Chief Financial Officer
Mr. Timothy Ogden White J.D.	President
Ms. Yiyuan Yin Ph.D.	Founder, VP of Technology & Acting Secretary
Dr. Xiao-Jun Ma Ph.D.	Chief Technology Officer
Dr. Stephen A. Williams M.D., Ph.D.	Chief Scientific Officer
Dr. Yuling Luo Ph.D.	Co-Founder, Chairman & CEO

FAQs

What is Alamar Biosciences, Inc. share price today?

Alamar Biosciences, Inc. share price today is $30.31 as on September 3, 2026 at 8:39 pm IST. Alamar Biosciences, Inc. share today touched a day high of $31.05 and a low of $29.60.

What is the 52 week high and 52 week low for Alamar Biosciences, Inc. share?

Alamar Biosciences, Inc. share touched a 52 week high of $0.00 on January 1, 1970 and a 52 week low of $0.00 on January 1, 1970. Alamar Biosciences, Inc. stock price today i.e. September 3, 2026 at 8:39 pm IST is trending at $30.31,which is -Infinity% down from its 52 week high and Infinity% up from its 52 week low.

What is Alamar Biosciences, Inc.'s market capitalisation today?

Alamar Biosciences, Inc. market capitalisation is $0.00T as on September 3, 2026 at 8:39 pm IST.

How to invest in Alamar Biosciences, Inc. Stock (ALMR) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Alamar Biosciences, Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Alamar Biosciences, Inc. Shares that will get you 0.0495 shares as per Alamar Biosciences, Inc. share price of $30.31 per share as on September 3, 2026 at 8:39 pm IST.

What is the minimum amount required to buy Alamar Biosciences, Inc. Stock (ALMR) from India?

Indian investors can start investing in Alamar Biosciences, Inc. (ALMR) shares with as little as ₹94.475 or $1 (as of September 3, 2026 at 8:39 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹944.75 in Alamar Biosciences, Inc. stock (as per the Rupee-Dollar exchange rate as on September 3, 2026 at 8:39 pm IST). Based on Alamar Biosciences, Inc. share’s latest price of $30.31 as on September 3, 2026 at 8:39 pm IST, you will get 0.3299 shares of Alamar Biosciences, Inc.. Learn more about fractional shares .